Evox Therapeutics competitorsClear all

Evox Therapeutics's top competitors include Protalex, Exosome Diagnostics and Codiak Biosciences.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Evox Therapeutics
Evox Therapeutics
Evox Therapeutics is a biotechnology company.
Protalex
Protalex
Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.
Exosome Diagnostics
Exosome Diagnostics
Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.
Codiak Biosciences
Codiak Biosciences
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Founding Date
Founding Date
2016
Founding Date
1999
Founding Date
2008
Founding Date
2015
Type
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Oxford, GB HQ
Solna, SE
Locations
Florham Park, US HQ
Locations
Waltham, US HQ
Martinsried, DE
Athens, US
Huntsville, US
Mobile, US
Montgomery, US
Opelika, US
see more
Locations
Cambridge, US HQ
Employees
Employees
1292% increase
Employees
233% decrease
Employees
864% decrease
Employees
101
Valuation ($)
Valuation ($)
N/A
Valuation ($)
615.2 k
Valuation ($)
N/A
Valuation ($)
403.1 m
Twitter followers
Twitter followers
319
Twitter followers
240
Twitter followers
1.4 k
Twitter followers
177
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
1
Alexa Website Rank
Alexa Website Rank
347225
Alexa Website Rank
463207
Alexa Website Rank
266272
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
1.9
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$2.9m (FY, 2020)
Net income
Net income
N/A
Net income
($5m) (FY, 2018)
Net income
N/A
Net income
($91.7m) (FY, 2020)

Funding

Latest funding round
Latest funding round
$ 96m (7 months ago)
Latest funding round
N/A
Latest funding round
$ 30m (about 4 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 158.6m
Total funding raised
N/A
Total funding raised
$ 112.1m
Total funding raised
$ 168.5m
For sources of this data, please see the company profile

View company profiles

Protalex
HQ
Florham Park, US
Employees
2↓ 33% decrease

Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.

View company
Exosome Diagnostics
HQ
Waltham, US
Employees
86↓ 4% decrease

Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.

View company
Codiak Biosciences
HQ
Cambridge, US
Employees
101

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.

View company